ASTA Draft Risk Profile Comments
ASTA issued a comment to the Food and Drug Administration (FDA) in March 2014 regarding the FDA's Draft Risk Profile on Pathogens and Filth in Spice.
03/03/2014 at 5:15 am
1
Related Resources
Coalition Comments to FDA Requesting Sesame Labeling Compliance Date Clarification
ASTA signed onto FBIA coalition comments to the Food and Drug Administration (FDA) in April 2022, requesting that the FDA clarify that the compliance date under the Food Allergy Safety, Treatment, Education, and Research Act (FASTER) means that food products containing sesame must be labeled with a sesame allergen statement on or after January 1, 2021 and that products labeled before that do not need to be in compliance with the FASTER Act.
ASTA Comments to FDA on Allergen Thresholds
ASTA issued comments to the Food and Drug Administration (FDA) in May 2013 regarding allergen thresholds, advocating for FDA's role to protect public health and the food supply by adopting allergen policies based on sound science and thoughtful policy.
